FEBS Journal Special Issue on CRISPR/Cas9 Gene Editing by news.wiley.com
Reporter: Aviva Lev-Ari, PhD, RN
2.1.5.10 Federation of European Biochemical Societies FEBS Journal Special Issue on CRISPR/Cas9 Gene Editing by news.wiley.com – State of CRISPR/Cas9 Science on 9/2016, Volume 2 (Volume Two: Latest in Genomics Methodologies for Therapeutics: Gene Editing, NGS and BioInformatics, Simulations and the Genome Ontology), Part 2: CRISPR for Gene Editing and DNA Repair
FEBS Journal Special Issue on CRISPR

FEBS Journal Special Issue on CRISPR/Cas9
The FEBS Journal
The discovery of CRISPR in archaea and bacteria
The FEBS Journal
Design, execution, and analysis of pooled in vitro CRISPR/Cas9 screens
The FEBS Journal
Next stop for the CRISPR revolution: RNA-guided epigenetic regulators
The FEBS Journal
Using CRISPR/Cas to study gene function and model disease in vivo
The FEBS Journal
Prospects and challenges of CRISPR/Cas genome editing for the study and control of neglected vector-borne nematode diseases
The FEBS Journal
Genome Engineering Tools for Building Cellular Models of Disease
The FEBS Journal
CRISPR guide RNA design for research applications
The FEBS Journal
Off-target effects of engineered nucleases
The FEBS Journal
Stacking up CRISPR against RNAi for therapeutic gene inhibition
The FEBS Journal
From: Wiley <e-service@wiley.com>
Reply-To: Wiley <e-service@wiley.com>
Date: Thursday, October 6, 2016 at 8:03 AM
To: Aviva Lev-Ari <AvivaLev-Ari@alum.berkeley.edu>
Subject: CRISPR – Read now the latest research and applications everybody is talking about
Our e-Books on Genomics include CRISPR/Cas9 Chapters, as follows:
Leave a Reply